---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-019005"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T07:42:21.515145+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences Q1 2025 revenue $6.8M up 1%; net loss narrows to $2.4M

## Summary
- Revenue $6.8M (+1% YoY); gross margin expanded 790 bps to 53.5%.
- Net loss $2.4M (EPS -$0.58) vs $3.4M loss (-$0.96) in Q1 2024.
- Adjusted EBITDA improved to -$0.55M from -$1.3M; operating expenses fell 5% to $5.7M.
- International revenue grew 8% YoY, now 36% of total; DTC drove 32% more psoriasis patients.
- Cash at quarter-end $7.8M; operating cash flow improved to -$0.55M.

## SEC filing metadata
- accession: 0001140361-25-019005
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036125019005/0001140361-25-019005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036125019005/ef20049049_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-019005
- JSON: https://secwatch.observer/filing/0001140361-25-019005.json
- Plain text: https://secwatch.observer/filing/0001140361-25-019005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.